“Capturing” the Benefits of Dual-Therapy Stent Technology: Is This a Promise or Reality?

Roxana Mehran; Gennaro Giustino

doi:10.1016/j.jcin.2016.03.035

“Capturing” the Benefits of Dual-Therapy Stent Technology: Is This a Promise or Reality?

Roxana Mehran
, Gennaro Giustino

Research output: Contribution to journal › Editorial

4 Scopus citations

Original language	English
Pages (from-to)	1135-1137
Number of pages	3
Journal	JACC: Cardiovascular Interventions
Volume	9
Issue number	11
DOIs	https://doi.org/10.1016/j.jcin.2016.03.035
State	Published - 2016

Keywords

COMBO stent
DES
PCI

Access to Document

10.1016/j.jcin.2016.03.035

Cite this

@article{04ff766a96af46d286917fdf4104df8d,

title = "“Capturing” the Benefits of Dual-Therapy Stent Technology: Is This a Promise or Reality?",

keywords = "COMBO stent, DES, PCI",

author = "Roxana Mehran and Gennaro Giustino",

note = "Funding Information: Dr. Mehran has received institutional research grant support from The Medicines Company, Bristol-Myers Squibb/Sanofi, Lilly/Daiichi Sankyo, Regado Biosciences, and STENTYS; is a consultant for Abbott Vascular, AstraZeneca, Boston Scientific, Covidien, CSL Behring, Janssen Pharmaceuticals, Merck, and Sanofi; and has equity in and is a shareholder of Endothelix, Inc. Dr. Giustino has reported that he has no relationships relevant to the contents of this paper to disclose. ",

year = "2016",

doi = "10.1016/j.jcin.2016.03.035",

language = "English",

volume = "9",

pages = "1135--1137",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "11",

}

TY - JOUR

T1 - “Capturing” the Benefits of Dual-Therapy Stent Technology

T2 - Is This a Promise or Reality?

AU - Mehran, Roxana

AU - Giustino, Gennaro

N1 - Funding Information: Dr. Mehran has received institutional research grant support from The Medicines Company, Bristol-Myers Squibb/Sanofi, Lilly/Daiichi Sankyo, Regado Biosciences, and STENTYS; is a consultant for Abbott Vascular, AstraZeneca, Boston Scientific, Covidien, CSL Behring, Janssen Pharmaceuticals, Merck, and Sanofi; and has equity in and is a shareholder of Endothelix, Inc. Dr. Giustino has reported that he has no relationships relevant to the contents of this paper to disclose.

PY - 2016

Y1 - 2016

KW - COMBO stent

KW - DES

KW - PCI

UR - https://www.scopus.com/pages/publications/84975520546

U2 - 10.1016/j.jcin.2016.03.035

DO - 10.1016/j.jcin.2016.03.035

M3 - Editorial

C2 - 27209249

AN - SCOPUS:84975520546

SN - 1936-8798

VL - 9

SP - 1135

EP - 1137

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 11

ER -